About the event
Our 2023 Investment Forum looked beyond short-term market forces towards “The Next Investment Horizon”. Our aim was to consider the direction of markets not just in the coming weeks and months, but the coming years and decades.
We’d like to thank everyone that took part in our holographic fund-raising game. We topped up the money raised to give £1,000 to each of our four chosen charities – Durrell Rewild Carbon, London Wildlife Trust, Dress for Success and the Hackney Foodbank.
And we hope you all enjoy our AXA IM honey, produced by our hives of British black bees in Kent, if you took one away with you.
It was a wonderful day of insight and interest. Thanks to our external speakers and to everyone internally who worked so hard to make it a fantastic day.
Guest speakers reflected the future focus
Henry Curr, economics editor at The Economist, had a timely discussion with AXA IM Core Investments CIO Chris Iggo on the impact of shock events on the global economy and markets.
We also heard from award-winning futurist Matthew Griffin on the trends that are reshaping our world, from AI to quantum computing to demographic and environmental change.
Our Charity Commitment
Fixed Income update
Nick Hayes, head of total return and fixed income asset allocation
Nicolas Trindade, portfolio manager, short duration bonds

Find out more about fixed income investing with AXA IM
Whatever the market conditions, our pioneering short duration and agile strategic bond approach could help keep your investment plans on track.
Find out moreTrends in Tech Investing
Jeremy Gleeson, portfolio manager, AXA Framlington Global Technology Fund
Brad Reynolds, portfolio manager, AXA World Funds Metaverse

Find out more about investing in technology with AXA IM
At the heart of this evolution are innovative companies driving change across the entire economy – including how we work, shop, build relationships and find information.
Find out moreTreating Alzheimer's Disease and Obesity: A Compelling Opportunity for healthcare equities
Linden Thomson, portfolio manager, AXA Framlington Biotech Fund
Cinney Zhang, portfolio manager, AXA Framlington Biotech Fund

Find out more about investing in biotech with AXA IM
Biotechnology is a burgeoning specialist field that is transforming the way diseases are treated.
Find out moreAddressing Global Environmental Challenges with Listed Equities
Anna Vänäänen, head of listed impact equity
Tom Atkinson, portfolio manager

Find out more about listed impact equity at AXA IM
Equity investing offers the opportunity to share in the returns generated by companies around the world, whether they are established leaders or dynamic smaller companies.
Find out moreDisclaimer
Not for Retail distribution: this marketing communication is intended exclusively for Professional, Institutional, Qualified or Wholesale Investors / Clients, as defined by applicable local laws and regulation. Circulation must be restricted accordingly.
This communication does not constitute an offer to buy or sell any AXA Investment Managers group of companies’ (‘the Group’) product or service and should not be regarded as a solicitation, invitation or recommendation to enter into any investment transaction or any other form of planning. It is provided to you for information purposes only. The views expressed do not constitute investment advice, do not necessarily represent the views of any company within the Group and may be subject to change without notice. Whilst every care is taken, no representation or warranty (including liability towards third parties), express or implied, is made as to the accuracy, reliability or completeness of the information contained herein. The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested. Due to this and the initial charge that is usually made, an investment is not usually suitable as a short term holding. Before making an investment, investors should read the relevant Prospectus and the Key Investor Information Document, which provide full product details including investment charges and risks. The information contained herein is not a substitute for those documents or for independent advice. Some of the investment vehicles mentioned may not be available in certain jurisdictions. Please check the countries in which they are registered with the asset manager. Issued in the U.K. by AXA Investment Managers UK Limited, which is authorised and regulated by the Financial Conduct Authority in the U.K. Registered in England and Wales, No: 01431068. Registered Office: 22 Bishopsgate, London, EC2N 4BQ.
Risk Warning
The value of investments, and the income from them, can fall as well as rise and investors may not get back the amount originally invested.